Neha Patel, DO
Associate Professor of Clinical Pediatrics (Endocrinology and Diabetes)
Department: Pediatrics
Contact information
CHOP Specialty Care Center, Princeton at Plainsboro
101 Plainsboro Road
Plainsboro, NJ 08536
101 Plainsboro Road
Plainsboro, NJ 08536
Office: (609) 520-1717
Fax: (215) 590-3053
Fax: (215) 590-3053
Education:
B.S. (Major: Biology, Minor: Chemistry)
Virginia Commonwealth University, 2005.
D.O.
Edward Via College of Osteopathic Medicine , 2009.
Permanent linkB.S. (Major: Biology, Minor: Chemistry)
Virginia Commonwealth University, 2005.
D.O.
Edward Via College of Osteopathic Medicine , 2009.
Selected Publications
Tallon EM, Ebekozien O, Sanchez J, Staggs VS, Ferro D, McDonough R, Demeterco- Berggren C, Polsky S, Gomez P, Patel NS, Prahalad P, Odugbesan O, Mathias P, Lee JM, Smith C, Shyu C, Clements MA.id=ebb7a43055: Impact of diabetes status and related factors on COVID- 19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection. Diabetes Research and Clinical Practice Page: doi: 10.1016, Dec 2022 Notes: epub ahead of print.Mistry S, Tonyushkina KN, Benavides VC, Choudhary A, Huerta-Saenz L, Patel NS,Mahmud FH, Libman I, Sperling MA: A Centennial Review of Discoveries and Advances in Diabetes: Children and Youth. Pediatric Diabetes 23(7): 926-943, Nov 2022.
Alonso GT, Ebekozien O, Gallagher MP, Rompicherla S, Lyons SK, Choudhary A, Majidi S, Pinnaro CT, Balachandar S, Gangat M, Curda Roberts AJ, Marks BE, Creo A, Sanchez J, Seeherunvong T, Jimenez-Vega J, Patel NS, Wood JR, Gabriel L, Sumpter KM, Wilkes M, Rapaport R, Cymbaluk A, Wong JC, Sanda S, Albanese-O'neill A.: Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. Journal Of Diabetes 13(3): 681-687, Aug 2021.
Miller R, Ashraf AP, Gourgari E, Gupta A, Kamboj MK, Kohn B, Lahoti A, Mak D, Mehta S, Mitchell D, Patel N, Raman V, Reynolds DG, Yu C, Krishnan S.: SARS-CoV-2 infection and pediatric endocrine disorders: Risks and management considerations. Endocrinology, Diabetes and Metabolism 4(3): e00262, July 2021.
Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Sadler LS, Stults- Kolehmainen M, Weinzimer SA, Grey M.l: Feasibility and safety of a group physical activity program for youth with type 1 diabetes. Pediatric Diabetes 4(6): 450-459, June 2019.
Siebel S, Galderisi A, Patel NS, Carria LR, Tamborlane WV, Sherr JL.: Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy. Diabetes Technology and Therapeutics 21(3): 101-104, March 2019.
Siebel S, Patel NS, Galderisi A, Carria LR, Tamborlane WV, Sherr J.: “Suppression of Ketogenesis in Type 1 Diabetes Is Not Delalyed by SGLT2 Inhibitor Therapy.” 78th Scientific Sessions of the American Diabetes Association, Orlando FL, July 2018.
Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Stults-Kolehmainen M, Weinzimer SA. Grey M.: “Bright 1 Bodies: Extending the Bright Bodies Family-Based Intensive Lifestyle Therapy to Adolescents with Type 1 Diabetes.” Annals of Behavioral Medicine 52, S281, May 2018.
Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Stults-Kolehmainen M, Weinzimer SA. Grey M.: “Safety and Health Outcomes of a Physical Activity Program for Adolescents with Type 1 Diabetes.” Annual Meeting of the American College of Sports Medicine, Minneapolis,MN May 2018.
Patel NS, Van Name MA, Cengiz E, Carria LR, Weinzimer SA, Tamborlane WV, Sherr JL: Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study. Diabetes Technology & Therapeutics 11(6): 618-622, Nov 2017.